
Injectable, Structural Regenerative Implant for Cartilage Care
Protect • Repair • Regenerate
Cartilage injuries can turn simple movement into a challenge. Without timely treatment, damage may progress and increase the risk of arthritis or future joint replacement.
At Liquid Cartilage, our goal isjoint preservation and regeneration—not replacement. WithChondroFiller®, we deliver advanced, evidence-led care on Harley Street.

Cartilage provides the smooth, low-friction surface that lets your joints move comfortably. It doesn’t readily self-repair, but with the right scaffold and biological cues,regeneration is possible.
Act early to preserve more of what you have.

ChondroFiller® is an acellular,biologic collagen scaffold delivered in liquid form. Once placed, itgels within minutes, filling the defect and providing a framework that invites your cells to rebuild cartilage.
Think of it like “epoxy” for cartilage—without the plastic.
One treatment. One step. A chance to keep your joint for the long term.


ChondroFiller® sits in a different class—structural regenerative implant.
| Treatment | Analogy | What it Does | Limitation |
|---|---|---|---|
| HA (Hyaluronic Acid) | WD-40 | Improves lubrication for short-term comfort | Temporary; does not regenerate tissue |
| Arthrosamid® | Silicone | Acts on the synovium to reduce pain signalling | Not regenerative; literature notes complication rates up to 30% |
| ChondroFiller® | Epoxy resin | Fills defects, stabilises, and promotes true cartilage repair | Most robust injectable option for structural repair |
ChondroFiller®: our structural, regenerative approach to focal cartilage defects.
Small joints: thumb, fingers, elbow, AC joint, toes, TMJ…
From £2,100
Large joints: knee, hip, shoulder, ankle
From £2,800
Best for knee, hip, shoulder
From £6,500 (knee), £9,500 (hip/shoulder)
Our proprietary MSC Co-Delivery Technique
Introductory offer: your consultation fee is credited toward treatment if you proceed.

Quick, no-obligation chat

Comprehensive assessment with Prof. Paul Lee

Injection, Keyhole, or Liquid Cartilage™

Precise and minimally invasive



Cartilage damage won’t reverse on its own—yet with the right plan it can beprotected, repaired, and regenerated.
At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.
(Consultation fee credited towards treatment if you proceed.)
Everything you want to know about ChondroFiller® at Liquid Cartilage.
ChondroFiller® is an acellular collagen gel that fills cartilage defects and forms a scaffold for your own cells to regenerate healthy tissue. Unlike temporary injections, it supports hyaline-like restorationfor smoother motion and protection long-term.
HA or Arthrosamid® may give short-term pain relief, while ChondroFiller® aims to rebuild cartilage. Compared with replacement, it preserves your natural joint and avoids prosthesis risks. Our approach is regenerate-first.
Studies show +30 IKDC in knees,+33 Harris Hip Score in hips, and improved ankle metrics. MRI (MOCART) typically reads 70–87. Globally,>19,000 cases support safety and function.
Best for focal defects up to 6 cm² in knees, hips, ankles, or small joints. Active younger patients often benefit, but older patients may qualify if surrounding cartilage is stable.
Delivered via precise injection orkeyhole surgery. The gel sets in minutes. Expectpartial weight-bearing ~6 weeks, steady return to cycling/swimming, and most sports around~12 months alongside specialist rehab.
Harley Street location; UK ICRS Centre of Excellence. Led byProf. Paul Lee, with advanced options likeLiquid Cartilage™ (ChondroFiller® + cells) to prioritise preservation.
Discover what makes ChondroFiller® unique at Liquid Cartilage.

ChondroFiller presents a novel, minimally invasive treatment for cartilage injuries, using a cell-free type I collagen gel to promote natural repair in damaged joints. Unlike traditional multi-step surgeries, this one-step arthroscopic procedure delivers the gel precisely via malleable needles, reducing recovery time and patient discomfort. Expert assessment by MSK Doctors ensures personalized care, optimizing outcomes for those suffering from full-thickness chondral defects. This innovative approach offers hope for improved joint function and faster healing, marking a significant advancement in orthopedic cartilage repair.

Persistent ankle pain after sprains often stems from cartilage damage. Innovative treatments like ChondroFiller and stem cell therapy offer promising repair options. ChondroFiller is a simpler, one-step, minimally invasive procedure using a cell-free collagen matrix that supports natural cartilage healing without cell extraction. In contrast, stem cell therapy involves harvesting, processing, and injecting cells in multiple steps, making it more complex and time-consuming. Both methods improve joint function and reduce pain, but ChondroFiller typically allows quicker recovery with fewer hospital visits. Consulting experienced professionals ensures personalized care and optimal outcomes. Understanding these differences helps patients make informed decisions tailored to their lifestyle and needs.

Persistent ankle pain after a sprain can result from unnoticed damage to the talus cartilage, a key component for smooth joint movement. While most sprains heal with simple care, some patients experience chronic discomfort due to focal chondral defects often missed on standard scans. ChondroFiller, a novel collagen gel treatment, offers a minimally invasive solution that promotes cartilage repair and regeneration. Clinical studies demonstrate its safety, effective integration, and potential to restore joint function. Post-treatment rehabilitation supports recovery, with many patients noticing improvements within six months. Early diagnosis and personalized care from orthopaedic specialists are crucial for optimal outcomes. ChondroFiller presents a promising alternative to traditional methods for those with persistent ankle pain seeking to regain mobility and reduce discomfort.

Persistent ankle pain after sprains often results from cartilage damage, which traditional treatments like debridement and microfracture aim to address. Debridement removes damaged tissue but doesn't regenerate cartilage, while microfracture encourages fibrocartilage repair with variable durability. ChondroFiller introduces a novel cell-free collagen matrix scaffold that promotes more natural cartilage regeneration, showing promising clinical outcomes, particularly for small to medium defects. This less invasive approach reduces inflammation and supports healing, with patients reporting improved function and satisfaction. Optimal treatment depends on individual injury characteristics and expert medical advice, highlighting the importance of personalized care in managing ankle cartilage injuries.

ChondroFiller, a collagen-based injectable treatment, offers a minimally invasive solution for cartilage injuries by promoting new cartilage growth in damaged joints. Recent studies demonstrate significant pain relief and improved joint function after just one procedure, particularly in younger patients with small cartilage defects. Unlike traditional microfracture surgery, ChondroFiller creates a supportive matrix facilitating stem cells to regenerate cartilage, supported by positive MRI findings. Personalized assessment by specialists, including clinical tests and patient history, ensures optimal outcomes and realistic expectations. Although promising, ChondroFiller is not suitable for all cartilage conditions and may require additional treatments for some. Consultation with qualified healthcare professionals is essential for tailored care and successful cartilage repair.

ChondroFiller is an innovative collagen-based treatment for repairing small cartilage injuries, promoting natural tissue growth and joint recovery. This minimally invasive procedure acts as a scaffold inviting stem cells to regenerate healthy cartilage, reducing pain and improving mobility. Developed with expertise from Professor Paul Lee and MSK Doctors, the treatment involves careful pre-procedure preparation, including lifestyle adjustments, followed by a structured recovery plan with immobilization and physiotherapy. Clinical studies report an 80% success rate with faster healing and fewer risks compared to traditional surgeries. Patients can gradually resume low-impact activities within months and return to high-impact sports after about a year. Expert guidance ensures optimal long-term joint health, making ChondroFiller a promising solution for cartilage repair and enhanced joint function.